• Firefly Luciferase mRNA: Boosting mRNA Delivery with 5-moUTP

  2026-05-29

  EZ Cap™ Firefly Luciferase mRNA (5-moUTP) delivers robust, low-immunogenicity bioluminescent reporting thanks to Cap 1 capping and 5-methoxyuridine modification. This article details optimized workflows, troubleshooting strategies, and new insights from LNP delivery advances—enabling researchers to maximize translational efficiency and assay sensitivity.

• AEBSF.HCl in Protease Inhibition: Workflows and Troubleshoot

  2026-05-28

  AEBSF.HCl (4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride) empowers researchers to dissect protease-driven mechanisms in neurodegeneration and cell death with unmatched precision. This guide offers actionable protocols, advanced troubleshooting, and strategic insights for maximizing AEBSF.HCl’s value in translational research workflows.

• Salinomycin: Mechanistic Insights and Translational Frontier

  2026-05-28

  Explore the advanced mechanistic basis and translational potential of Salinomycin, a polyether ionophore antibiotic, in hepatocellular carcinoma research. This article uniquely bridges molecular insights with practical assay design, distinguishing itself with a deep analysis of ionophore transport and toxicity.

• Gap19: Precision Modulation of Cx43 Hemichannels for Neuropr

  2026-05-27

  Explore how Gap19, a selective connexin 43 hemichannel blocker, enables advanced neuroprotection and inflammation research. This article delves into the mechanistic, assay-design, and translational implications of Gap19’s unique selectivity and recent breakthroughs in the Cx43/NF-κB pathway.

• α2-AR Agonists Curb Immune Rejection in Osteosarcoma Recurre

  2026-05-27

  This study demonstrates that selective activation of α2-adrenergic receptors using hydrogel-based delivery of agonists can significantly reduce osteosarcoma recurrence by modulating immune responses. These findings suggest a promising new strategy for post-surgical cancer immunotherapy, underpinned by robust mechanistic and translational insights.

• JC-1 Mitochondrial Membrane Potential Assay Kit: Advanced Wo

  2026-05-26

  The JC-1 Mitochondrial Membrane Potential Assay Kit from APExBIO delivers high-sensitivity, ratiometric detection of mitochondrial health for robust apoptosis and function analysis. Its optimized workflow, integrated controls, and compatibility with diverse sample types make it a transformative tool for immunomodulatory and cancer research.

• PtrbZIP12 Phosphorylation Drives Drought Tolerance in Poplar

  2026-05-26

  The referenced study demonstrates that phosphorylation of the bZIP transcription factor PtrbZIP12 enhances drought resistance in Populus trichocarpa by activating stress-responsive genes PtrDHN and PtrPOD. This work provides mechanistic insight into how post-translational modifications regulate plant responses to environmental stress, offering a framework for improving drought tolerance in trees.

• Super-Enhancer RNA Drives NPC Metastasis via NPM1/c-Myc/NDRG

  2026-05-25

  This study uncovers how carcinogen-induced super-enhancer RNA (seRNA-NPCm) promotes nasopharyngeal carcinoma (NPC) metastasis through activation of the NPM1/c-Myc/NDRG1 axis. The findings advance understanding of NPC progression and highlight potential molecular targets for prognostic evaluation and therapeutic intervention.

• Sulfo-Cy3 Azide: Advanced Bioconjugation Reagent for Click C

  2026-05-25

  Sulfo-Cy3 azide empowers researchers with highly water-soluble, photostable fluorescent labeling for protein, cell, and oligonucleotide tracking in complex biological systems. This bioconjugation reagent transforms Click Chemistry workflows by minimizing fluorescence quenching and eliminating organic co-solvents—delivering reproducible, high-sensitivity imaging even in demanding neurodevelopmental studies.

• Nicotine Signaling Accelerates CKD Progression in Smokers

  2026-05-24

  Jain and Jaimes (2013) provide a comprehensive review elucidating how nicotine, acting through non-neuronal nicotinic acetylcholine receptors, exacerbates chronic kidney disease (CKD) progression in smokers. Their synthesis of clinical and experimental evidence highlights oxidative stress and pro-fibrotic pathways as central mechanisms, underscoring the need for targeted interventions.

• ALDOB K87 Lactylation Drives Mitochondrial Fission in PH

  2026-05-23

  A recent study reveals that lactylation of aldolase B at lysine-87 orchestrates mitochondrial fission and metabolic reprogramming in pulmonary hypertension (PH). These findings uncover a mechanistic link between metabolic shifts and pathological smooth muscle cell proliferation, offering new therapeutic targets for PH.

• Metabolomics Uncovers Resistance in Carbapenemase-Producing

  2026-05-22

  This study applies LC-MS/MS metabolomics and machine learning to rapidly differentiate carbapenemase-producing Enterobacterales (CPE) from non-CPE strains using metabolite biomarkers. The findings highlight metabolomic profiling as a promising tool for early resistance detection and deeper mechanistic understanding in antibiotic resistance research.

• ABT-737: BCL-2 Protein Inhibitor for Precision Cancer Apopto

  2026-05-22

  ABT-737, a potent BCL-2 protein inhibitor, enables precise and reproducible induction of apoptosis in diverse cancer models while minimizing toxicity to normal cells. Leveraging breakthrough in vitro methodologies, this workflow guide empowers researchers to dissect cell death dynamics and optimize anti-tumor strategies across hematologic and solid malignancies.

• AO/PI Double Staining Kit: Reliable Cell Viability & Apoptos

  2026-05-21

  This article explores real-world laboratory challenges in cell viability and apoptosis detection, demonstrating how the AO/PI Double Staining Kit (SKU K2238) delivers reproducible, high-clarity results. Evidence-based Q&A scenarios address experimental design, data interpretation, and product selection, guiding researchers to optimize workflows using APExBIO's validated kit.

• AZD-3463 in ALK/IGF1R-Driven Cancer: Mechanistic Insights &

  2026-05-21

  Explore the mechanistic depth of AZD3463, a potent ALK/IGF1R inhibitor, and discover how its nuanced effects on signaling pathways enable more precise, evidence-based cancer research. This article uniquely integrates pathway regulation, combination therapy considerations, and advanced protocol design.

459 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page